Loading…
Loading…
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NHS and 80,000+ other tickers.
See exactly how NHS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NHS and 80,000+ other tickers.
The Neuberger High Yield Strategies Fund Inc., identified by its symbol NHS, is a closed-end investment vehicle focused on fixed income. Established by Neuberger Berman LLC and overseen by Neuberger Berman Investment Advisers LLC, it allocates capital to debt instruments in global markets. The fund primarily targets high-yield bonds issued by companies across numerous sectors, such as automotive components and equipment, airlines, the broader automotive industry, electronics, healthcare services, packaging, integrated and service-based telecommunications, gaming, and natural gas distribution…
Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) shares passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $6.79 and traded as low as $6.11. Neuberger Berman High Yield Strategies Fund shares last traded at $6.12, with a volume of 68,514 shares.
Ventripoint's VMS+ platform to be evaluated alongside a second AI technology in a landmark NHS study exploring earlier detection of chemotherapy-related heart damage Toronto, Ontario – TheNewswire – July 20, 2026 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) a leader in the application of artificial intelligence to echocardiography, today announced that its VMS+ technology has been selected for use in AIRES (Artificial Intelligence Reconstruction of Echocardiography Study), a newly launched clinical research study at The Royal Wolverhampton NHS Trust (RWT) in the United Kingdom.
As small-business owners face rising operating costs, ComEd is marking a major milestone: more than 100,000 small businesses across northern Illinois have compl
Neuberger High Yield Strategies Fund is downgraded to a sell due to persistent NAV erosion and unsustainable distributions. NHS trades at a 6.6% discount to NAV and offers a 17.4% yield, but earnings consistently fail to cover payouts, risking further capital deterioration. Leverage at 26.7% and 98% below-investment-grade exposure amplifies risks in a rising rate and higher default environment.
NEW YORK, June 30, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on July 31, 2026, has a record date of July 15, 2026, and has an ex-date of July 15, 2026.